1/30/2007 | SS | Market Commentary: Motorola rockets on Icahn news; Calpine drifts off on profit taking; Lexicon lifted; Triad up after close
|
10/31/2006 | BT | Lexicon reiterated at sector perform by RBC
|
10/31/2006 | BT | Lexicon ends Q3 with $53 million of cash and investments, revenues up 40%
|
10/24/2006 | PP | Market Commentary: Linn wraps $305 million PIPE; Environmental Power to close $15 million convertible preferreds sale
|
10/23/2006 | BT | Market Commentary: Connetics gains 46% on merger; Replidyne falls 45%, Forest down 6%; Adeza loses 16%; Amgen off
|
10/23/2006 | PP | Market Commentary: Lexicon Genetics stock off on $40 million stock sale; Iomai to close $10 million PIPE
|
10/23/2006 | BTPP | New Issue: Lexicon secures $40 million from direct placement of stock
|
9/6/2006 | BT | Lexicon Genetics tests LX6171 in cognitive disorders trial
|
8/1/2006 | BT | Lexicon reports second-quarter revenues up 16% to $16.2 million
|
7/11/2006 | BT | Lexicon Genetics licenses Cellectis' homologous recombination technology
|
6/29/2006 | BT | Lexicon seeks U.K. approval for study of LX6171 in cognitive disorders
|
6/29/2006 | BT | Lexicon rated at sector perform by RBC
|
6/14/2006 | BT | Lexicon says it will make regulatory filings for advanced programs this year
|
6/14/2006 | PP | Market Commentary: WCA Waste secures $75 million from convertibles; OccuLogix stock off on $30 million PIPE
|
6/13/2006 | PP | Market Commentary: Lexicon Genetics gets $75 million equity line; Monterey Gourmet Foods secures $12.5 million from PIPE
|
6/13/2006 | BTPP | New Issue: Lexicon Genetics secures $75 million equity line
|
6/13/2006 | BT | Market Commentary: Lexicon drops 5%; Genitope stays steady; Vivus, Arena decline amid their respective obesity drug news
|
5/31/2006 | BT | Bristol-Myers Squibb extends neuroscience alliance with Lexicon Genetics
|
3/2/2006 | BT | Lexicon gets $5 million milestone as Takeda chooses LG474 as development target
|
2/22/2006 | BT | Market Commentary: Axcan annihilated; Lexicon lifted; Advanced Magnetics draws interest; CombiMatrix climbs
|
12/20/2005 | BT | Lexicon achieves two milestones, $20 million in payments from Genentech collaboration
|
12/19/2005 | BT | Market Commentary: Pfizer, other Big Pharmas zoom; generic names Barr, Teva plunge; Cubist, Rigel, Xoma, Lexicon off
|
12/1/2005 | BT | Market Commentary: Rigel Pharma tromped; Oxigene, Biopure launch follow-on deals; Lexicon, LabCorp, Quigley higher
|
11/11/2005 | BT | Lexicon Genetics, Taconic Farms reach deal for marketing, distribution of knockout mice
|
1/21/2005 | CV | Lexicon Genetics files $150 million shelf
|